| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 12.556 | 9.893 | 5.084 | 12.910 | 14.098 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -12.556 | -9.893 | -5.084 | -12.910 | -14.098 |
| Net Profit/Loss - EUR | - | - | - | - | - | -12.556 | -9.893 | -5.084 | -12.910 | -14.098 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Natural Symbiotics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 13.434 | 7.382 | 5.791 | 6.578 | 5.883 |
| Inventories | - | - | - | - | - | 0 | 2.022 | 2.028 | 2.022 | 0 |
| Receivables | - | - | - | - | - | 1.026 | 2.351 | 2.610 | 3.082 | 3.155 |
| Cash | - | - | - | - | - | 12.408 | 3.009 | 1.153 | 1.474 | 2.728 |
| Shareholders Funds | - | - | - | - | - | -12.515 | -22.130 | -27.283 | -40.110 | -53.984 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 25.949 | 29.511 | 33.074 | 46.688 | 59.867 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Natural Symbiotics S.r.l.